These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 37158834)

  • 1. Proteogenomic characterization of ferroptosis regulators reveals therapeutic potential in glioblastoma.
    Wang X; Zhang H; Zhang M; Zhang X; Mao W; Gao M
    BMC Cancer; 2023 May; 23(1):415. PubMed ID: 37158834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferroptosis Suppressive Genes Correlate with Immunosuppression in Glioblastoma.
    Deng S; Zheng Y; Mo Y; Xu X; Li Y; Zhang Y; Liu J; Chen J; Tian Y; Ke Y
    World Neurosurg; 2021 Aug; 152():e436-e448. PubMed ID: 34062295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CircRNF10 triggers a positive feedback loop to facilitate progression of glioblastoma via redeploying the ferroptosis defense in GSCs.
    Wang C; Zhang M; Liu Y; Cui D; Gao L; Jiang Y
    J Exp Clin Cancer Res; 2023 Sep; 42(1):242. PubMed ID: 37723588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of temozolomide on glioma cells is sensitized by RSL3-induced ferroptosis but negatively correlated with expression of ferritin heavy chain 1 and ferritin light chain.
    Yang FC; Wang C; Zhu J; Gai QJ; Mao M; He J; Qin Y; Yao XX; Wang YX; Lu HM; Cao MF; He MM; Wen XM; Leng P; Cai XW; Yao XH; Bian XW; Wang Y
    Lab Invest; 2022 Jul; 102(7):741-752. PubMed ID: 35351965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginsenoside Rg5 inhibits glioblastoma by activating ferroptosis via NR3C1/HSPB1/NCOA4.
    Zhang G; Hu J; Li A; Zhang H; Guo Z; Li X; You Z; Wang Y; Jing Z
    Phytomedicine; 2024 Jul; 129():155631. PubMed ID: 38640858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative proteogenomic characterization of glioblastoma.
    Asif S; Fatima R; Krc R; Bennett J; Raza S
    CNS Oncol; 2019 Jun; 8(2):CNS37. PubMed ID: 31290679
    [No Abstract]   [Full Text] [Related]  

  • 7. FHOD1 is upregulated in glioma cells and attenuates ferroptosis of glioma cells by targeting HSPB1 signaling.
    Zhang F; Wu L; Feng S; Zhao Z; Zhang K; Thakur A; Xu Z; Liang Q; Liu Y; Liu W; Yan Y
    CNS Neurosci Ther; 2023 Nov; 29(11):3351-3363. PubMed ID: 37211949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferroptosis Modulation: Potential Therapeutic Target for Glioblastoma Treatment.
    de Souza I; Ramalho MCC; Guedes CB; Osawa IYA; Monteiro LKS; Gomes LR; Rocha CRR
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioblastoma Relapses Show Increased Markers of Vulnerability to Ferroptosis.
    Kram H; Prokop G; Haller B; Gempt J; Wu Y; Schmidt-Graf F; Schlegel J; Conrad M; Liesche-Starnecker F
    Front Oncol; 2022; 12():841418. PubMed ID: 35530303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of Tumor Immune Microenvironment and Prognostic Value of Ferroptosis-Related Genes, and Candidate Target Drugs in Glioblastoma Multiforme.
    Zhang X; Jin S; Shi X; Liu S; Li K; Liu G; Zhong S; Liu T; Li L; Tao S; Zhai Q; Bao N; Ren L; Wu Y; Bao Y
    Front Pharmacol; 2022; 13():898679. PubMed ID: 35571123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of SSBP1 as a ferroptosis-related biomarker of glioblastoma based on a novel mitochondria-related gene risk model and in vitro experiments.
    Su J; Li Y; Liu Q; Peng G; Qin C; Li Y
    J Transl Med; 2022 Sep; 20(1):440. PubMed ID: 36180956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXP3 promote the progression of glioblastoma via inhibiting ferroptosis mediated by linc00857/miR-1290/GPX4 axis.
    Cao W; He Y; Lan J; Luo S; Sun B; Xiao C; Yu W; Zeng Z; Lei S
    Cell Death Dis; 2024 Apr; 15(4):239. PubMed ID: 38561331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of ferroptosis signature to evaluate the predict prognosis and immunotherapy in glioblastoma.
    Zhu X; Zhou Y; Ou Y; Cheng Z; Han D; Chu Z; Pan S
    Aging (Albany NY); 2021 Jul; 13(13):17655-17672. PubMed ID: 34244461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated HSPB1 Expression Is Associated with a Poor Prognosis in Glioblastoma Multiforme Patients.
    Wang Z; Fang Z; Gui Y; Xi B; Xie Z
    J Neurol Surg A Cent Eur Neurosurg; 2024 Jul; ():. PubMed ID: 38959943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Ferroptosis-Related Prognostic Risk Score Model to Predict Clinical Significance and Immunogenic Characteristics in Glioblastoma Multiforme.
    Xiao D; Zhou Y; Wang X; Zhao H; Nie C; Jiang X
    Oxid Med Cell Longev; 2021; 2021():9107857. PubMed ID: 34804371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HSP27 protects against ferroptosis of glioblastoma cells.
    Yuan F; Sun Q; Zhang S; Ye L; Xu Y; Xu Z; Liu B; Zhang S; Chen Q
    Hum Cell; 2022 Jan; 35(1):238-249. PubMed ID: 34791597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatostatin induces ferroptosis through inhibition of the AKT/mTORC1/GPX4 signaling pathway in glioblastoma.
    Cai J; Ye Z; Hu Y; Ye L; Gao L; Wang Y; Sun Q; Tong S; Zhang S; Wu L; Yang J; Chen Q
    Cell Death Dis; 2023 Mar; 14(3):211. PubMed ID: 36966152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juglone induces ferroptosis in glioblastoma cells by inhibiting the Nrf2-GPX4 axis through the phosphorylation of p38MAPK.
    Guo F; Ling G; Qiu J; Li J; Gan Y; Yu Y; Tang J; Mo L; Piao H
    Chin Med; 2024 Mar; 19(1):52. PubMed ID: 38520025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CircLRFN5 inhibits the progression of glioblastoma via PRRX2/GCH1 mediated ferroptosis.
    Jiang Y; Zhao J; Li R; Liu Y; Zhou L; Wang C; Lv C; Gao L; Cui D
    J Exp Clin Cancer Res; 2022 Oct; 41(1):307. PubMed ID: 36266731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLC1A5 enhances malignant phenotypes through modulating ferroptosis status and immune microenvironment in glioma.
    Han L; Zhou J; Li L; Wu X; Shi Y; Cui W; Zhang S; Hu Q; Wang J; Bai H; Liu H; Guo C; Cao H; Chao M; Hu Y; Mou Y; Jiao Y; Feng D; Wang L; Qu Y
    Cell Death Dis; 2022 Dec; 13(12):1071. PubMed ID: 36566214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.